Cytokinetics Inc Earnings

Cytokinetics Inc’s revenue jumped 318.14% since last year same period to $1.94Mn in the Q3 2025. On a quarterly growth basis, Cytokinetics Inc has generated -97.1% fall in its revenue since last 3-months.

Cytokinetics Inc’s net profit fell -90.71% since last year same period to $-306.18Mn in the Q3 2025. On a quarterly growth basis, Cytokinetics Inc has generated -127.86% fall in its net profits since last 3-months.

Cytokinetics Inc’s net profit margin jumped 54.39% since last year same period to -15814.98% in the Q3 2025. On a quarterly growth basis, Cytokinetics Inc has generated -7758.53% fall in its net profit margins since last 3-months.

Cytokinetics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.57 - a -0.64% fall from last quarter’s estimates.

Cytokinetics Inc’s earning per share (EPS) estimates for the current year stand at -1.57.

Cytokinetics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Cytokinetics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.